Chimeric antigen receptor and methods of use thereof
AssigneeThe Regents of the University of California
InventorsChia-Yung Wu, James Onuffer, Wendell A. Lim
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a heterodimeric, conditionally active chimeric antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence encoding the CAR. The present disclosure provides cells genetically modified to produce the CAR. A CAR of the present disclosure can be used in various methods, which are also provided.
Claims27
One or more isolated nucleic acids comprising one or more nucleotide sequences encoding a first polypeptide and a second polypeptide of a heterodimeric chimeric antigen receptor (CAR), wherein the first and the second polypeptides are two separate polypeptides, such that when present in a eukaryotic cell membrane, the first polypeptide of the CAR binds an antigen and the CAR dimerizes in the presence of a small molecule dimerizer to produce titratable activity of the CAR, wherein:
- a) the first polypeptide comprises:
- i) an extracellular antigen binding domain that specifically binds to the antigen on target cells;
- ii) a transmembrane domain;
- and
- iii) a first member of a dimerization pair;
- and
- b) the second polypeptide comprises:
- i) a transmembrane domain;
- ii) a second member of the dimerization pair;
- and
- iii) an intracellular signaling domain comprising an immunoreceptor tyrosine-based activation motif (ITAM), wherein the intracellular signaling domain provides signal transduction activity,
- wherein the second polypeptide does not comprise an antigen-binding domain,
- wherein the first polypeptide, the second polypeptide or both the first and second polypeptides comprise an intracellular costimulatory polypeptide.
Dependencies are inferred from the claim text.